RxDoctor Payments Data

Sean Fuller, MD

Family Medicine · Irmo, SCNPI 1063488054

Payments from drug & device makers

$6,629in general payments, 2019–2025

Across 445 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$953
  • Novo Nordisk$446
  • Abbott$414
  • AstraZeneca$403
  • Otsuka America Pharmaceutical, Inc.$385
  • Bayer$324
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$6,629100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,629 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$161,168
Medicare patients
396
Services billed
2,425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$137,612
MounjaroTirzepatide63$94,414
JardianceEmpagliflozin85$81,837
FarxigaDapagliflozin Propanediol71$73,804
EliquisApixaban63$53,309
RybelsusSemaglutide17$33,145
LinzessLinaclotide35$30,719
TrulicityDulaglutide20$27,995
XareltoRivaroxaban32$26,428
JanumetSitagliptin Phos/Metformin Hcl14$20,763
RexultiBrexpiprazole12$17,021
JanuviaSitagliptin Phosphate12$15,618
MyrbetriqMirabegron12$14,022
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,697
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$11,247

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$446$170,757120 claims
Lilly USA, LLCMounjaro, Trulicity$147$122,40983 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$403$88,778100 claims
Boehringer IngelheimJardiance, Synjardy$164$88,10098 claims
PfizerEliquis$72$53,30963 claims
AbbVieLinzess, Restasis, Savella$953$42,75057 claims
MerckJanumet, Januvia$52$36,38126 claims
Johnson & JohnsonXarelto$263$26,42832 claims
Otsuka America Pharmaceutical, Inc.Rexulti$385$17,02112 claims
Astellas Pharma US IncMyrbetriq$40$14,02212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Irmo

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →